Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

temporary image

Margaret Klauzinska, Ph.D.

Dr. Klauzinska has expertise in hematopoiesis, the bone marrow niche, epitranscriptomics, and aging. She manages a portfolio of grants related to myeloid malignancies (i.e., chronic and acute myeloid leukemia) and hematologic cancer stem cells.  

 

Research Programs

Dr. Klauzinska also manages an NIH cooperative agreement program and is involved in an NIH research initiative: 

 

Background

Prior to her working in DCB, Dr. Klauzinska was a program director in the Division of Blood Diseases and Resources (DBDR) at the National Heart, Lung, and Blood Institute (NHLBI) where she oversaw nonmalignant hematology programs and projects. 

 

Education: 
Ph.D., Molecular Biology, Polish Academy of Sciences


 

  • Updated:
Email